Infective Endocarditis Surgery Using Conventional Prosthetic Valves Versus Cryopreserved Aortic Homograft
NCT05253469 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 760
Last updated 2025-07-01
Summary
: Evidence suggested that autologous or allogeneic tissue is more suitable to synthetic material in an infected field. Given the unwillingness of some surgeons to use artificial foreign materials, such as conventional mechanical or stent xenograft valve prostheses, cryopreserved aortic homografts (CAH) have been recommended revealing favorable outcomes in aortic valve endocarditis (AVE) surgery (1-5). This aspect is even more evident in cases involving prosthetic valve endocarditis (PVE) and other complex and aggressive lesions involving the aortic root and intervalvular fibrosa with abscess formation. However, most of these reports are fixed on single-arm observational studies without comparing CAH with conventional prostheses.
The key question of this study is to establish the difference in treatment failure (death, recurrent aortic valve regurgitation and reoperation), all-cause and cause-specific (cardiac vs noncardiac) mortality, hospitalizations for heart failure during follow-up (structural/non structural valve deterioration, thromboembolism and recurrent endocarditis) in patients who received the CAH vs conventional mechanical or stent xenograft valve prostheses for aortic valve replacement (AVR) secondary to infective endocarditis (IE)
Conditions
- Infective Endocarditis
- Heart Failure
Interventions
- PROCEDURE
-
Cryopreserved Aortic Homograft
CAH is used for aortic root reconstruction and for repair of mitro-aortic curtain (emicommando procedure) and it is inserted as miniroot . In cases of PVE the infected prosthesis is removed with aggressive debridement of all infected and necrotic tissue. (7)The coronary ostia are prepared for reconstruction of aortic root. In complex valve endocarditis involving aortic and mitral valve a double homograft may be used.Mitro-aortic endocarditis intervalvular fibrosa is largely involved.The abscess cavity is precisely bounded and debrided. and a double homograft is used for the reconstruction (commando procedure
- PROCEDURE
-
Stented/Non stented xenograft
The insertion of stented/non stented xenograft may be performed using separate or continuos stich with or without teflon pledget. Biological valves may be implated alone or combined with polyester or pericardial patch when reconstruction of annulus is required. In cases of aggressive lesions requiring root and /or intervalvular fibrosa reconstruction the choice of prosthetic bioroot using bioprosthetic valve is considered acceptable alternatives to CAH although it should be guided by the surgeon's experience
- PROCEDURE
-
Mechanical prostheses
The insertion of conventional mechanical valves may be performed using separate or continuos stich with or without teflon pledget. Mechanical prostheses may be implated alone or combined with polyester or pericardial patch when reconstruction of annulus is required. In cases of aggressive lesions requiring root and /or intervalvular fibrosa reconstruction the choice of prosthetic valved conduit with a mechanical valve is considered acceptable alternatives to CAH although it should be guided by the surgeon's experience
Sponsors & Collaborators
-
Campus Bio-Medico University
collaborator OTHER -
Henri Mondor University Hospital
collaborator OTHER -
Universita degli Studi di Genova
collaborator OTHER -
University of Bristol
collaborator OTHER -
Aberdeen Royal Infirmary
collaborator OTHER -
Centre Cardiologique du Nord
lead OTHER
Principal Investigators
-
Francesco Nappi, MD · Centre Cardiologique du Nord
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-01
- Primary Completion
- 2024-12-31
- Completion
- 2026-12-01
Countries
- France
Study Locations
More Related Trials
-
Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation.
NCT04009434 ·Status: UNKNOWN ·Phase: NA
-
Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT05739253 ·Status: RECRUITING
-
Comparison Between Three Types of Stented Pericardial Aortic Valves
NCT01522352 ·Status: UNKNOWN ·Phase: NA
-
Repair Versus Non-repair of the Aortic Arch in Type A Aortic Dissection
NCT05912634 ·Status: ENROLLING_BY_INVITATION
-
Transcatheter Aortic Valve Implantation Without Predilation
NCT01539746 ·Status: COMPLETED ·Phase: NA
-
Impact of Predilatation Between Self-expanding Valves
NCT04157920 ·Status: COMPLETED ·Phase: NA
-
Comparison of Sutureless Vs. Standard Biological Prostheses for Surgical Aortic Valve Replacement
NCT03965065 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Self-expandable and Balloon-expandable Valves in Patients With Ascending Aortic Dilation
NCT06743568 ·Status: RECRUITING ·Phase: NA
-
Perioperative Hemodynamic and Microcirculatory Physiological Study During TAVI
NCT06154642 ·Status: COMPLETED
-
Study of Platelet Activation by Severe Aortic Stenosis and Its Correction by Transcatheter Aortic Valve Implantation
NCT02504632 ·Status: COMPLETED ·Phase: NA
-
Symetis ACURATE Neo™ Valve Implantation SAVI TF Registry
NCT02306226 ·Status: COMPLETED
-
To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Insufficiency
NCT05424653 ·Status: UNKNOWN ·Phase: NA
-
Early Versus Deferred Aortic Valve Replacement in Patients With Moderate Aortic Stenosis and Mitral Regurgitation
NCT05310461 ·Status: RECRUITING ·Phase: NA
-
Clinical Outcomes of Patients Undergoing CABG Surgery With VEST Supported Venous Grafts
NCT04761068 ·Status: RECRUITING
-
RanDOmized stUdy Comparing Both Latest Generation Self-Expanding Valves and a Minimalist approaCH vs. Standard Of Care In transCathEter Aortic Valve Implantation
NCT05036018 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
REpositionable Versus BallOOn-expandable Prosthesis for Trans-catheter Aortic Valve Implantation
NCT02668484 ·Status: COMPLETED ·Phase: NA
-
Cerebrovascular EveNts in Patients Undergoing TranscathetER Aortic Valve Implantation With Balloon-expandable Valves Versus Self-expandable Valves.
NCT03588247 ·Status: COMPLETED
-
Influence of Original Native Aortic Valve Lesion (Stenosis or Steno-insufficiency vs. Insufficiency) on Post-implant Structural Bioprosthetic Degeneration After Aortic Valve Replacement
NCT06964035 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Endothelial Dysfunction During Aortic Valvular Replacement by Bioprosthesis With and Without Extracorporeal Circulation
NCT03135496 ·Status: COMPLETED
-
Microvascular Function in Patients Undergoing Transcatheter Aortic Valve Implant (TAVI) for Severe Symptomatic Aortic Stenosis: Association With Myocardial Fibrosis
NCT05326126 ·Status: COMPLETED ·Phase: NA
-
Interest of Cardiac Computed Tomography to Optimize and Improve the Procedure of TAVI
NCT01672268 ·Status: COMPLETED ·Phase: PHASE3
-
Surgical Management of Valvular Endocarditis
NCT04572529 ·Status: UNKNOWN
-
Outcomes for Patients With Ascending Aortic Dilation Who Underwent TAVR
NCT07148973 ·Status: COMPLETED
-
Retrospective Observational Study of Patients With a Sutureless Aortic Valve Implanted in the Cardiovascular and Thoracic Surgery Department of Dijon CHU
NCT03259945 ·Status: COMPLETED
-
Effects of Aortic Valve Replacement on Myocardial T1 Values in Severe Aortic Valve Stenosis
NCT05404100 ·Status: COMPLETED